Samnyte Tattoo Numbing Creams Recalled Due to Failure to Meet Child-Resistant Packaging Requirement; Sold Exclusively at Amazon.com; Risk of Poisoning; Imported by Liu Xianli
CPSC recall 23070 · announced December 15, 2022 · Sainite Trading (shenzhen) Co · 9,000 units affected
The product
The recall involves Samnyte Tattoo Numbing Cream sold in 60ml and contains Lidocaine 5% with Vitamin E. The product was sold in a white tube with a flip-top closure. The drug facts label is on the back.
The hazard
The packaging is not child resistant as required by the Poison Prevention Packaging Act. The tattoo numbing cream contains lidocaine, posing a risk of poisoning to young children if they ingest it.
What to do (per CPSC)
Consumers should immediately stop using the recalled cream and store it in a location out of reach of children. Contact Liu Xianli for instructions on how to dispose of the product to receive a full refund. Liu Xianli is contacting all known purchasers directly. Remedy type: Refund Replace
Notes
Incidents (per CPSC): None reported
Sold at: Online at www.amazon.com from April 2022 through October 2022 for about $23.
Consumer contact: Liu Xianli by email at auoorhealth@outlook.com or online at http://m6z.cn/6lfCv7 or www.samnyte.xyz and click on "RECALL" for more information.
Source: U.S. Consumer Product Safety Commission public recall data. This page reports official records and is not legal, medical, or repair advice.